North America Over-the-Counter (OTC) Drugs Market Growth, Trends, and Forecasts (2017 - 2022)

The North American market for OTC drugs is estimated to be USD 34.09 billion in 2014 and is expected to reach USD 39.41 billion by the end of 2019. During this period, the market is expected to grow at a CAGR of 2.95%.

North America Over-the-Counter (OTC) Drugs Market-Market Dynamics

The report details several factors driving and restraining the market. Some of these are listed below.


Contributing to the growth of the market are factors such as:

Growing demand for the use of medication for minor health issues that do not require a doctorvisit

Increased awareness among the population regarding the potential benefits of using the OTC drugs

Potential savings made by the healthcare industry on a yearly basis

Growing inclination from the pharmaceutical industries to convert their products from Rx to OTC category


Factors such as the potential abuse of the drugs when sold without a proper prescription and the risk of making incorrect self-diagnosis, which could result in the use of wrong medication, have been restraining the market growth.

The market is segmented on the basis of the type of product and geography. The product can be further segmented into categories such as analgesics, cough & cold products, gastrointestinal, dermatological products, vitamins, minerals, sleep aids, ophthalmic products and weight-loss products.

The report also offers a detailed analysis and trends for the USA, Canada, and Mexico. The USA is the biggest market for OTC drugs in the North American region. It accounts for more than 80% of the market in this region.

Although the market share is high in the North American region, the USAshare is less when compared to the other countries on a global forefront. This can be due to the strict regulatory measures taken by the US government in the labeling of drugs as OTC. But in recent times, there has been a change in opinion regarding the OTC market. The potential benefits have been identified and as a result, OTC drugs have been made more accessible. According to statistics, it is estimated that nearly 81% of the adults use OTC medicine as the first response to minor health ailments and that nearly 70% of the parents give their children OTC medicine to treat an immediate medical symptom. Following the USA, Canada is the second biggest market in North America, followed by Mexico.

Some of the key players in the market are:



Bayer Healthcare

Boehringer Ingelheim GmbH

Bristol- Myers Squibb

Cardinal Health


What the Report Offers

Market definition for the North American OTC drugs market along with identification of key drivers and restraints for the market.

Market analysis for the North American OTC drugs market, with region-specific assessments and competition analysis on a global and regional scale.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their market share.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

A comprehensive analysis of the major trends, innovations and associated prospects for market growth over the coming half a decade.

An ideal opportunity for industry consultants and other interested and allied parties to gain a critical insight into the factors driving and restraining the market, in addition to opportunities offered.

Wide-ranging information provided about the leading market players and the major strategies adopted by them.


1.1 Report Description

1.2 Research Methodology

1.3 Stakeholders


2.1 Key Findings

2.2 Market Overview


3.1 Market Introduction

3.2 Market Dynamics

3.2.1 Market Drivers

3.2.2 Market Restraints

3.2.3 Market Opportunities

3.2.4 Porter's Five Force Analysis Threat of a new entrant Internal Rivalry Buyer Bargaining Power Supplier Bargaining Power Threat of substitutes

4. Market Segmentation

4.1 By Product Category

4.1.1 Cough, Cold, and Flu Products

4.1.2 Analgesics

4.1.3 Dermatological Products

4.1.4 Gastrointestinal Products

4.1.5 Vitamins

4.1.6 Minerals

4.1.7 Weight Loss/Dietary Products

4.1.8 Ophthalmic Products

4.1.9 Sleep Aids

4.1.10 Smoking Cessation Aids

4.1.11 Others

4.2 By Geography

4.2.1 North America USA Canada Mexico

5. Rx To OTC Switch Industry

5.1 Market Overview

5.2 Impact of the Switch on the Healthcare System

5.3 Market Forecasts and growth

5.4 Market Segmentation

6. Regulatory Framework

6.1 North America

6.1.1 USA

7. Competitive Landscape

7.1 Mergers & Acquisitions

7.2 New Product Launches

7.3 Expansion

7.4 Collaborations

7.5 Market Share Analysis

7.6 Price Value Analysis

8. Company Profiles

8.1 Abbott

8.2 AstraZeneca

8.3 Bayer Healthcare

8.4 Boehringer Ingelheim GmbH

8.5 Bristol- Myers Squibb

8.6 Cardinal Health

8.7 GlaxoSmithKline

8.8 Insight Pharmaceuticals

8.9 Johnson & Johnson

8.10 Merck & Co

8.11 Novartis

8.12 Pfizer

8.13 Procter & Gamble

8.14 Reckitt Benckiser

8.15 Sanofi Aventis

9. Appendix

9.1 Abbreviations

9.2 Sources

9.3 Bibliography

9.4 Disclaimer

Content are not available

Choose License Type